Guide to Obesity Step Therapy
GLP-1 talk is all over Vive. Worries about rising costs for the medications — and obesity itself — have health plans and their partners scrambling to find the right strategy for their people. After all, obesity already accounts for more than 20% of health expenditures in the US.
Curious how obesity step therapy can make a difference in costs and outcomes?